Summary of Progyny FY Conference Call (March 11, 2026) Company Overview - **Company**: Progyny (NasdaqGS: PGNY) - **Industry**: Fertility Benefits and Assisted Reproductive Technology Key Points Financial Performance - **4Q Performance**: Progyny exceeded guidance with a growth of approximately 20% in 2025, excluding one customer [1] - **Client Retention**: The company achieved a 99% client retention rate, with about 30% of clients expanding their benefits [2] - **Revenue Guidance**: The company has guided for a revenue growth of about 7% for the year, aligned with membership growth [34] Membership and Utilization - **Membership Estimate**: The estimated number of lives for 2026 was revised to 7.2 million, attributed to administrative updates rather than layoffs or macroeconomic factors [3] - **Utilization Rate**: The historical utilization rate has been consistent, ending last year at 1.04%. The company expects to remain within the low to middle of its historical utilization range for the current year [8] - **Impact of Macroeconomic Factors**: Utilization is primarily driven by the biological need for fertility assistance rather than macroeconomic conditions, such as tax refunds [10][11] Competitive Landscape - **Market Position**: Progyny competes more with managed care organizations (MCOs) that offer fertility benefits rather than standalone competitors. The company maintains a high win rate when clients decide to add fertility benefits [13][17] - **MCO Engagement**: MCOs have not become more aggressive in the fertility space due to lack of financial incentives, as they do not profit from increased utilization of fertility benefits [18][19] Product Expansion and Opportunities - **Client Expansion**: 30% of clients added to their offerings, including cycles and new products like menopause and postpartum support [20][22] - **Fully Insured Market**: Progyny is expanding into the fully insured market, addressing the needs of small employers who typically lack access to fertility benefits [24][25] - **Sales Cycle**: The sales cycle for fully insured buyers aligns with traditional cycles, with renewals generally occurring in the fourth quarter [28] Risk Management - **Contract Duration**: Fully insured buyers operate on annual contracts, allowing for premium adjustments based on experience [31] - **Utilization Risk**: Initial utilization risk exists with smaller populations, but as the risk pool grows, it will be managed similarly to self-insured populations [32] Future Outlook - **Growth Expectations**: The company expects to add approximately 1 million lives annually, with potential incremental contributions from new products [42] - **Long-term Margin Opportunities**: Future margin expansion is anticipated as investments taper off and operational efficiencies improve, particularly through AI and care management enhancements [39][40] Additional Insights - **Pipeline Status**: The current pipeline is primarily carryover from previous years, with positive expectations for the upcoming sales season [41] - **Market Positioning**: Progyny is well-positioned to expand its addressable market and maintain a competitive edge over standalone competitors and MCOs [42] This summary encapsulates the key insights and data points from the Progyny FY Conference Call, highlighting the company's performance, market dynamics, and future strategies.